INVITRO ACTIVITIES OF AMPICILLIN-SULBACTAM AND CEFOPERAZONE-SULBACTAM AGAINST OXACILLIN-SUSCEPTIBLE AND OXACILLIN-RESISTANT STAPHYLOCOCCI

被引：7

作者：

BARRY, AL

JONES, RN

机构：

[1] Clinical Microbiology Inst., Tualatin, OR 97062

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1990年 / 34卷 / 09期

关键词：

D O I：

10.1128/AAC.34.9.1830

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Ampicillin-sulbactam and cefoperazone-sulbactam were tested against staphylococci that were collected from 40 different medical centers throughout the United States. Oxacillin-resistant strains were resistant to both drug combinations, but oxacillin-susceptible strains were uniformly susceptible. The latter included strains with borderline susceptibility ot oxacillin and methicillin.

引用

收藏

页码：1830 / 1832

页数：3

相关论文

共 19 条

[1] PROPOSED CHANGES IN INTERPRETIVE CRITERIA AND POTENCY OF AMPICILLIN AND AMPICILLIN-SULBACTAM DISKS FOR SUSCEPTIBILITY TESTS [J].

BARRY, AL ;

JONES, RN .

JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (04) :750-754

[2]

BARRY AL, 1977, AM J CLIN PATHOL, V67, P489

[3]

BUSH K, 1988, Clinical Microbiology Reviews, V1, P109

[4]

CHAMBERS H F, 1988, Clinical Microbiology Reviews, V1, P173

[5] LOW-LEVEL METHICILLIN RESISTANCE IN STRAINS OF STAPHYLOCOCCUS-AUREUS [J].

CHAMBERS, HF ;

ARCHER, G ;

MATSUHASHI, M .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (04) :424-428

[6] PENICILLIN-BINDING PROTEINS AND THE INTRINSIC RESISTANCE TO BETA-LACTAMS IN GRAM-POSITIVE COCCI [J].

FONTANA, R .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 16 (04) :412-416

[7] LOW-AFFINITY PENICILLIN-BINDING PROTEIN ASSOCIATED WITH BETA-LACTAM RESISTANCE IN STAPHYLOCOCCUS-AUREUS [J].

HARTMAN, BJ ;

TOMASZ, A .

JOURNAL OF BACTERIOLOGY, 1984, 158 (02) :513-516

[8] INVITRO ANTIMICROBIAL SPECTRUM, OCCURRENCE OF SYNERGY, AND RECOMMENDATIONS FOR DILUTION SUSCEPTIBILITY TESTING CONCENTRATIONS OF THE CEFOPERAZONE-SULBACTAM COMBINATION [J].

JONES, RN ;

BARRY, AL ;

PACKER, RR ;

GREGORY, WW ;

THORNSBERRY, C .

JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (09) :1725-1729

[9] OPTIMAL DILUTION SUSCEPTIBILITY TESTING CONDITIONS, RECOMMENDATIONS FOR MIC INTERPRETATION, AND QUALITY-CONTROL GUIDELINES FOR THE AMPICILLIN-SULBACTAM COMBINATION [J].

JONES, RN ;

BARRY, AL .

JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (10) :1920-1925

[10] THE CEFOPERAZONE-SULBACTAM COMBINATION - INVITRO QUALITIES INCLUDING BETA-LACTAMASE STABILITY, ANTIMICROBIAL ACTIVITY, AND INTERPRETIVE CRITERIA FOR DISK DIFFUSION TESTS [J].

JONES, RN ;

BARRY, AL ;

THORNSBERRY, C ;

WILSON, HW .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1985, 84 (04) :496-504